ASRS 2023: Topics at the annual meeting researchers found most exciting
September 8th 2023At the 2023 American Society of Retina Specialists meeting in Seattle, Washington, we asked some of the presenters, "What research here do you find exciting or interesting?" Here's what Diana Do, MD, Shawn Kavoussi, MD, and Durga Borkar, MD, MMCi had to say!
Read More
Our team spoke with several researchers and industry professionals at the 2023 American Society of Retina Specialists meeting in Seattle, Washington. We asked them, "What research here do you find exciting or interesting?" Here's what Tarek Hassan, MD, Nancy Lurker, and J. Fernando Arevalo, MD, PhD, FACS, FASRS, had to say.
Read More
Orbis celebrates 20 Years of Cybersight telemedicine platform, new app
September 5th 2023According to the company, the tool provides free access to training and mentors for eye care professionals in areas with the greatest need, and the new Cybersight mobile app expands access for eye care professionals through offline functionality.
Read More
ASRS 2023: Presenters share research from 2023 ASRS annual meeting they find exciting
September 4th 2023At the 2023 American Society of Retina Specialists meeting in Seattle, Washington, we asked some of the presenters, "What research here do you find exciting or interesting?" Here's what Ursula Schmidt-Erfurth, MD, Veena Raiji, MD, and Dante Pieramici, MD had to say.
Read More
Prevent Blindness declares September as Sports Eye Safety Month
September 1st 2023Prevent Blindness plans to educate the public on the risk of significant eye injuries and the need for the proper sports eye protection, with more than 32,000 sports-related eye injuries treated in 2022, up almost 20 percent from previous year.
Read More
UC Irvine researchers discover a nanobody which may lead to treatment for retinitis pigmentosa
September 1st 2023According to the university, a special antibody that is derived from llamas, called a nanobody, can stop the misfolding and the activation of Rhodopsin, a molecule whose mutations can lead to blindness.
Read More
OKYO Pharma reaches 90% enrollment mark in Phase 2 clinical trial of OK-101 to treat dry eye disease
September 1st 2023According to the company, full enrollment anticipated by first week of September. The phase 2 trial is designed as potential registration trial with pre-specified primary efficacy endpoints covering both a sign and symptom of DED.
Read More
USC-backed startup awarded grant for clinical trial of eye treatment
August 31st 2023According to the Keck School of Medicine of USC, the $12.4 million from the California Institute for Regenerative Medicine is the latest round of support for USC researcher Mark Humayun and a milestone in the development of a stem cell patch to treat advanced dry age-related macular degeneration.
Read More
This intellectual property protects Kiora's pipeline by covering multiple small molecule analogs, delivery methods, and several inflammatory-related therapeutic applications, including posterior non-infectious uveitis, extending market exclusivity for approved indications in the United States and Europe.
Read More
Study: Scientists develop new therapeutic model for potentially treating incurable eye diseases
August 24th 2023A team of researchers have successfully transplanted human microglia into a mouse retina to create a model for studying eye disease treatments, such as diabetic retinopathy, glaucoma and age-related macular degeneration.
Read More
Study: Few children – especially those with safety-net insurance – get vision checked at checkups
August 24th 2023According to researchers from University of Michigan and Duke University, children with Medicaid or other public insurance are far less likely than those with private insurance to have had a vision check in the last year at a primary care office.
Read More
Cochrane Review: Blue-light filtering glasses show inconclusive outcomes
August 23rd 2023Clinicians' expertise can help assess inconclusive findings about the benefits of blue-light filtering glasses. This enables them to offer informed guidance to patients concerned about eye strain and sleep quality.
Read More